3.76 (-%)
As of Nov 21, 2024
Source:
Alector, Inc is a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | (415) 231-5660 |
Industry | manufacturing |
CEO | Arnon Rosenthal Rosenthal, Ph.D. |
Website | www.alector.com |